Milan Panic, the man who said he was "born to fight" even when it wasn't a good idea, chose not to Wednesday, announcing that he would step down as chairman and chief executive of ICN ...

There has been speculation that ICN might buy back the 20% of Ribapharm now held by public stockholders. Before the announcement, Ribapharm shares rose 45 cents to $6.45, and ICN gained 11 cents ...

ICN Pharmaceuticals Inc. announced Wednesday that it is changing its name to Valeant Pharmaceuticals International, the latest move in a yearlong campaign by the Costa Mesa, Calif., drug company ...